DC CFAR Social and Behavioral Sciences Co-Director, Dr. Nina Yamanis, Promoted to Full Professor | | |
|
|
Please join us in congratulating Dr. Nina Yamanis on being promoted to the rank of Full Professor in the School of International Service (SIS) at American University (AU), effective September 1, 2024.
Dr. Yamanis is the Co-Director of the DC CFAR Social and Behavioral Sciences Core, Scientific Officer for the CFAR Adelante Program, and Acting Associate Dean for Graduate Education for the SIS at AU.
Dr. Yamanis’s current HIV-related work focuses on two different communities: her R21 in Tanzania focuses on a pilot social network intervention to reduce HIV and IPV among adolescent girls, and her work in Washington, DC focuses on the impact of immigration status on Latino/x men who have sex with men (MSM) and Latina/x transgender women.
| |
Share Your Abstract Title for AIDS - IAS 2024, 25th International AIDS Conference, July 22-26, 2024 | |
Dear DC CFAR Investigators,
Please let us know if you have had an abstract accepted for a poster, oral presentation, or are receiving an award at AIDS 2024, the 25th International AIDS Conference, in Munich, Germany from July 22-26, 2024. We would like to share this good news with your fellow DC CFAR investigators, including those who will also participate at AIDS- IAS 2024.
Please send the name of the award recipient, or for abstracts, the name of the presenting author, the title, whether it will be an oral or poster presentation, and the date and session of your presentation to DCCFAR@gwu.edu.
Please send this information by July 15, 2024.
| |
Updated HIV Language Guide Now Available from NIAID | |
Please see the updated HIV Language Guide from NIAID here. The guide includes language suggestions for communicating about HIV and related topics, particularly on the use of person-first, non-stigmatizing language.
This guide aims to help scientists, administrators, researchers, funded research networks, sites, centers, investigators, and stakeholders use fair, accurate, and respectful language as they draft protocols and develop communications and outreach materials.
Further information about the Guide is available on the NIH website here.
| | |
Recording Available – "Using the Prevention Toolbox" Plenary Session from HPTN 2024 Meeting, Moderated by DC CFAR Co-Director, Manya Magnus |
 |  | On June 17, 2024, Dr. Manya Magnus, DC CFAR Co-Director, moderated a session at the NIH-funded HIV Prevention Trials Network (HPTN) meeting entitled, "Using the Prevention Toolbox." Over 600 HIV prevention researchers from around the globe gathered in DC for its annual five-day meeting. Session speakers included Dr. Zubair Lukyazumi (Makerere University–Johns Hopkins University) who presented a new community-based protocol based in barber shops in Uganda; Dr. Jeffrey Stringer (University of North Carolina at Chapel Hill) who presented compelling findings regarding AI-enabled ultrasound to capture lay-provider measurements of birthweight outcomes in HIV-prevention studies; Dr. Romain Silhol (HPTN Modelling Centre and Imperial College) described innovative uses of modeling for identification of priority populations for HIV epidemic responses, and Dr. Mackenzie Cottrell (University of North Carolina at Chapel Hill) discussed research on on-demand PrEP dosing for women that will fill an urgent public health gap.
View the recording here.
| |
Announcing the Spring 2024 DC CFAR Pilot Awardees: Drs. Preethi Chandran (HU), Haijun Gao (HU), & Taisuke Izumi (AU) |  | |
Please join us in congratulating the following investigators who are the recipients of DC CFAR Pilot Awards in the Spring 2024 cycle: Dr. Preethi Chandran, Associate Professor of Chemical Engineering at Howard University, Dr. Haijun Gao, Assistant Professor of Physiology and Biophysics at Howard University, and Dr. Taisuke Izumi, Assistant Professor of Biology at American University.
Dr. Chandran's project is entitled, "Effect of environmental factors on interactions between HIV and vaginal mucosal barriers." Dr. Gao's project is entitled, "The effects of cabotegrevir on placental mitochondrial functions." Dr. Izumi's project is entitled, "Comprehensive Functional HIV Cure Strategy: The Role of HDAC, PARP, and Immune Checkpoint Inhibitors for Latency Reversal and Immune Activation."
To read full descriptions of their projects, and to view past recipients of the Traditional Pilot Awards Program, please visit the DC CFAR website here.
| | |
|
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to DCCFAR@gwu.edu.
| |
|
IAPAC 95-95-95 Targets Update
July 22, 2024
Munich Germany | Hybrid
IAS 2024
July 22-26, 2024
Munich, Germany
National LGBTQ+ Health Conference
August 15-17, 2024
Atlanta, GA
2024 National Ryan White Conference on HIV Care & Treatment
August 20-23, 2024
US Conference on HIV/AIDS (USCHA) 2024: Registration Open
September 12-15, 2024
New Orleans, LA
HIVR4P 2024, the 5th HIV Research for Prevention Conference (Registration Now Open and Application for Scholarships Available!)
October 6-10, 2024
Lima, Peru | Hybrid
Inter-CFAR Faith and Spirituality Research Collaborative | Registration Now Open!
October 21-22, 2024
Nashville, TN
International Workshop on HIV & Aging 2024
October 24-25, 2024
Washington, DC | Hybrid
Inaugural Dissemination and Implementation Science Institute - Registration Open
October 28-30, 2024
St. Louis, MO
International Conference on Stigma 2024
November 22-24, 2024
Washington, DC | Hybrid
For more DC CFAR events please see the calendar here.
| |
FUNDING, TRAINING, & MENTORING OPPORTUNITIES & SEMINARS | |
|
Apply Now – Senior Research Scientist Position, Department of Epidemiology, GW Milken School of Public Health – DC Cohort Longitudinal Study
The Department of Epidemiology of the GW Milken Institute School of Public Health (GWSPH) is recruiting for a Senior Research Scientist for a large NIH-funded HIV study, the DC Cohort. The DC Cohort is one of the largest urban HIV cohort studies in the US and is a longitudinal observational study of people living with HIV (PWH) and receiving care at 15 clinical sites in Washington, DC. The study captures clinical information on PWH in care and has been enrolling since 2011 in partnership with numerous clinical providers in Washington, DC, the DC Department of Health (DC DOH), and the National Institutes of Health (NIH). See job posting here.
NIDA/MIT SUD Ventures Program, Recruiting Now, Applications due July 15, 2024.
he NIDA/MIT SUD Ventures Program is an intense and immersive hybrid program consisting of live expert webinars, online courses, and an in-person Bootcamp in Cambridge, MA. he programs are open to researchers at academic institutions in the United States at any stage of their career. Learn more here.
CIRA Dissemination and Implementation Science Methods Core & R3EDI Seminar: "Harnessing the power of spatial data science to help end the HIV epidemic in the United States" July 15, 2:00PM ET
Please see the attached flyer for more information here, and the registration link here.
NIH UNITE Structural Racism and Health Workshop, July 18–19, 2024. Registration Open.
The National Institutes of Health’s UNITE initiative is hosting a two-day virtual workshop on July 18–19 entitled “Interdisciplinary Approaches to Understanding and Addressing Structural Racism and Health.”
This workshop will bring together researchers, clinicians, and community partners with expertise in fields such as social and natural sciences, law and criminal justice, education, public policy, social work—as well as biomedical, behavioral, and public health. Registration required and linked here.
National Institute on Aging (NIA) Pre-conference Workshop at AIDS 2024, Sunday, July 21 from 3:00 - 6:30
NIA will host Exploring the Intersection of HIV and Aging — A Geroscience Perspective. This session aims to delve into the translational potential of biological findings, including discoveries related to the hallmarks of aging, to become interventions for people living with HIV (PWH) or at risk of HIV acquisition. For more information and to register, visit the IAS website here.
NIDA HIV Seminar Series with Dr. Ricky Bluthenthal: Social and Political Determinants of HIV among People Who Use Drugs, July 31, 2024, 1:00pm ET
Please join NIDA's HIV Seminar Series, ft. Ricky Bluthenthal, Ph.D. Dr. Bluthenthal is a Distinguished Professor of Population and Public Health Sciences at the Keck School of Medicine of the University of Southern California. He conducts community-partnered research at the intersection of harm reduction and health disparities among people who use drugs. Register here.
ACTG Small Clinical Trials Advancing HIV Remission and Cure RFA: Letter of Intent REQUIRED. Next LOI due date September 5th (for applications due October 1st.)
More information here.
| |
NIH FUNDING OPPORTUNITIES | |
|
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-MH-25-180
Posting Date: June 14, 2024
Opening Date: October 08, 2024
Close Date: November 09, 2024
Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-MH-25-185
Posting Date: April 29, 2024
Opening Date: July 13, 204
Close Date: See announcement
Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-DK-25-013
Posting Date: February 29, 2024
Opening Date: June 30, 2024
Close Date: See announcement
High Priority HIV and Substance Use Research
Funding Opportunity Number: RFA-DA-25-060
Posting Date: January 17, 2024
Opening Date: July 15, 2024
Close Date: Various – See announcement
Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Trial Optional)
Funding Opportunity Number: RFA-HD-25-004
Posting Date: March 20, 2024
Opening Date: June 30, 2024
Close Date: July 30, 2024
Novel Preclinical Models of NeuroHIV in the cART Era (R61/R33 - Clinical Trial Not Allowed)
Posting Date: February 28, 2024
Estimated Publication Date of Notice of Funding Opportunity: June 05, 2024
First Estimated Application Due Date: October 21, 2024
Resource-Related Research Project (R24) Applications to Support Collaborative Implementation Science to End the HIV Epidemic
Funding Opportunity Number: NOT-AI-24-031
Posting Date: April 4, 2024
Opening Date: May 07, 2024
Close Date: January 08, 2025
Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-AI-24-011
Posting Date: March 21, 2024
Opening Date: June 30, 2024
Close Date: July 31, 2024
Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DK-25-001
Posting Date: November 30, 2023
Opening Date: February 20, 2024
Close Date: Various – See announcement
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Funding Opportunity Number: PAR-23-112
Posting Date: January 31, 2023
Opening Date: February 24, 2023
Close Date: Various – See announcement
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-018
Posting Date: August 21, 2023
Opening Date: July 5, 2024
Close Date: August 2024
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-001
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
| |
|
Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R21 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-MH-25-181
Posting Date: June 14, 2024
Opening Date: October 08, 2024
Close Date: November 09, 2024
Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)
Funding Opportunity Number: RFA-MH-25-186
Posting Date: April 29, 2024
Opening Date: July 13, 204
Close Date: See announcement
Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed)
Funding Opportunity Number: RFA-MD-24-005
Posting Date: March 1, 2024
Opening Date: May 22, 2024
Close Date: Various – See announcement
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional)
Funding Opportunity Number: NOT-NR-24-009
Estimated Publication Date of Notice of Funding Opportunity: April 2024
First Estimated Application Due Date: July 2024
Notice of Funding Opportunity: Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]
Funding Opportunity Number: RFA-OD-24-012
Open Date: April 24, 2024
Close Date: Non-HIV-related applications are due May 24, 2024 and HIV-related applications are due September 6, 2024.
Streamlining mental health interventions for youth living with HIV in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-MH-25-140
Posting Date: December 05, 2023
Opening Date: July 12, 2024
Close Date: August 13, 2024
Ending the HIV Epidemic (EHE) – Various
Funding Opportunity Number: NOT-AI-23-070
Posting Date: September 29, 2023
Opening Date: Various – See announcement
Close Date: Various – See announcement
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-060
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Funding Opportunity Number: NOT-MH-23-275
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
Funding Opportunity Number: RFA-OD-23-018
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Funding Opportunity Number: NOT-CA-23-070
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
| |
Click here for additional funding opportunities available from the National Institutes of Health. | |
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. | | |
| | | |
